Anzeige
Mehr »
Login
Freitag, 28.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kritischer Rohstoff, strategische Wende: Warum diese Aktie jetzt auf das Radar kluger Investoren gehört
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
28.03.25
07:00 Uhr
1,475 Euro
-1,475
-100,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,49007:00

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoIntelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win4
DoIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra128INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK...
► Artikel lesen
MiIntelligent Bio Solutions secures new U.S. patent3
MiIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry100Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned...
► Artikel lesen
MiEXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology1
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
DiIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch341NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
DiEXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch2
21.03.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report2
20.03.Intelligent Bio Solutions set to secure new US patent3
20.03.Intelligent Bio Solutions steht vor Erhalt eines neuen US-Patents4
20.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant3
12.03.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report14
21.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report7
21.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock4
20.02.Intelligent Bio Solutions Inc. Announces $2.6 Mln Common Stock Offering Pricing4
20.02.Intelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall3
20.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock7
19.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock4
13.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
13.02.INTELLIGENT BIO SOLUTIONS INC. - 10-K/A, Annual Report2
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1